Cost-Analysis for Toxicity Management in Advanced Squamous Non-Small Cell Lung Cancer- Nivolumab vs Docetaxel
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2150
https://www.valueinhealthjournal.com/article/S1098-3015(16)33516-1/fulltext
Title :
Cost-Analysis for Toxicity Management in Advanced Squamous Non-Small Cell Lung Cancer- Nivolumab vs Docetaxel
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33516-1&doi=10.1016/j.jval.2016.09.2150
First page :
A722
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2040